Literature DB >> 29241002

The Future of Multiplexed Eukaryotic Genome Engineering.

David B Thompson1,2, Soufiane Aboulhouda1,2, Eriona Hysolli1,2, Cory J Smith1,2, Stan Wang1,2, Oscar Castanon1,2,3, George M Church1,2.   

Abstract

Multiplex genome editing is the simultaneous introduction of multiple distinct modifications to a given genome. Though in its infancy, maturation of this field will facilitate powerful new biomedical research approaches and will enable a host of far-reaching biological engineering applications, including new therapeutic modalities and industrial applications, as well as "genome writing" and de-extinction efforts. In this Perspective, we focus on multiplex editing of large eukaryotic genomes. We describe the current state of multiplexed genome editing, the current limits of our ability to multiplex edits, and provide perspective on the many applications that fully realized multiplex editing technologies would enable in higher eukaryotic genomes. We offer a broad look at future directions, covering emergent CRISPR-based technologies, advances in intracellular delivery, and new DNA assembly approaches that may enable future genome editing on a massively multiplexed scale.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29241002      PMCID: PMC5880278          DOI: 10.1021/acschembio.7b00842

Source DB:  PubMed          Journal:  ACS Chem Biol        ISSN: 1554-8929            Impact factor:   5.100


  99 in total

Review 1.  Microcell-mediated chromosome transfer (MMCT): small cells with huge potential.

Authors:  Aideen M O Doherty; Elizabeth M C Fisher
Journal:  Mamm Genome       Date:  2003-09       Impact factor: 2.957

2.  SVA elements: a hominid-specific retroposon family.

Authors:  Hui Wang; Jinchuan Xing; Deepak Grover; Dale J Hedges; Kyudong Han; Jerilyn A Walker; Mark A Batzer
Journal:  J Mol Biol       Date:  2005-10-19       Impact factor: 5.469

3.  Sequencing the nuclear genome of the extinct woolly mammoth.

Authors:  Webb Miller; Daniela I Drautz; Aakrosh Ratan; Barbara Pusey; Ji Qi; Arthur M Lesk; Lynn P Tomsho; Michael D Packard; Fangqing Zhao; Andrei Sher; Alexei Tikhonov; Brian Raney; Nick Patterson; Kerstin Lindblad-Toh; Eric S Lander; James R Knight; Gerard P Irzyk; Karin M Fredrikson; Timothy T Harkins; Sharon Sheridan; Tom Pringle; Stephan C Schuster
Journal:  Nature       Date:  2008-11-20       Impact factor: 49.962

4.  A programmable Cas9-serine recombinase fusion protein that operates on DNA sequences in mammalian cells.

Authors:  Brian Chaikind; Jeffrey L Bessen; David B Thompson; Johnny H Hu; David R Liu
Journal:  Nucleic Acids Res       Date:  2016-08-11       Impact factor: 16.971

5.  Multiplexed and programmable regulation of gene networks with an integrated RNA and CRISPR/Cas toolkit in human cells.

Authors:  Lior Nissim; Samuel D Perli; Alexandra Fridkin; Pablo Perez-Pinera; Timothy K Lu
Journal:  Mol Cell       Date:  2014-05-15       Impact factor: 17.970

6.  Sequence- and structure-specific RNA processing by a CRISPR endonuclease.

Authors:  Rachel E Haurwitz; Martin Jinek; Blake Wiedenheft; Kaihong Zhou; Jennifer A Doudna
Journal:  Science       Date:  2010-09-10       Impact factor: 47.728

7.  A Multiplexed Single-Cell CRISPR Screening Platform Enables Systematic Dissection of the Unfolded Protein Response.

Authors:  Britt Adamson; Thomas M Norman; Marco Jost; Min Y Cho; James K Nuñez; Yuwen Chen; Jacqueline E Villalta; Luke A Gilbert; Max A Horlbeck; Marco Y Hein; Ryan A Pak; Andrew N Gray; Carol A Gross; Atray Dixit; Oren Parnas; Aviv Regev; Jonathan S Weissman
Journal:  Cell       Date:  2016-12-15       Impact factor: 41.582

Review 8.  Crossing the LINE Toward Genomic Instability: LINE-1 Retrotransposition in Cancer.

Authors:  Jacqueline R Kemp; Michelle S Longworth
Journal:  Front Chem       Date:  2015-12-16       Impact factor: 5.221

9.  CRISPR-Cas9 Can Inhibit HIV-1 Replication but NHEJ Repair Facilitates Virus Escape.

Authors:  Gang Wang; Na Zhao; Ben Berkhout; Atze T Das
Journal:  Mol Ther       Date:  2016-01-22       Impact factor: 11.454

10.  CRISPR/Cas9-Mediated Genome Editing of Herpesviruses Limits Productive and Latent Infections.

Authors:  Ferdy R van Diemen; Elisabeth M Kruse; Marjolein J G Hooykaas; Carlijn E Bruggeling; Anita C Schürch; Petra M van Ham; Saskia M Imhof; Monique Nijhuis; Emmanuel J H J Wiertz; Robert Jan Lebbink
Journal:  PLoS Pathog       Date:  2016-06-30       Impact factor: 6.823

View more
  12 in total

1.  Enabling large-scale genome editing at repetitive elements by reducing DNA nicking.

Authors:  Cory J Smith; Oscar Castanon; Khaled Said; Verena Volf; Parastoo Khoshakhlagh; Amanda Hornick; Raphael Ferreira; Chun-Ting Wu; Marc Güell; Shilpa Garg; Alex H M Ng; Hannu Myllykallio; George M Church
Journal:  Nucleic Acids Res       Date:  2020-05-21       Impact factor: 16.971

2.  Burly1 is a mouse QTL for lean body mass that maps to a 0.8-Mb region of chromosome 2.

Authors:  Cailu Lin; Brad D Fesi; Michael Marquis; Natalia P Bosak; Anna Lysenko; Mohammed Amin Koshnevisan; Fujiko F Duke; Maria L Theodorides; Theodore M Nelson; Amanda H McDaniel; Mauricio Avigdor; Charles J Arayata; Lauren Shaw; Alexander A Bachmanov; Danielle R Reed
Journal:  Mamm Genome       Date:  2018-05-08       Impact factor: 2.957

3.  Multiplex base- and prime-editing with drive-and-process CRISPR arrays.

Authors:  Qichen Yuan; Xue Gao
Journal:  Nat Commun       Date:  2022-05-19       Impact factor: 17.694

Review 4.  Synthetic evolution.

Authors:  Anna J Simon; Simon d'Oelsnitz; Andrew D Ellington
Journal:  Nat Biotechnol       Date:  2019-06-17       Impact factor: 54.908

5.  Unified rational protein engineering with sequence-based deep representation learning.

Authors:  Ethan C Alley; Grigory Khimulya; Surojit Biswas; Mohammed AlQuraishi; George M Church
Journal:  Nat Methods       Date:  2019-10-21       Impact factor: 28.547

6.  Establishment of genomic library technology mediated by non-homologous end joining mechanism in Yarrowia lipolytica.

Authors:  Qiuyan Bai; Shuai Cheng; Jinlai Zhang; Mengxu Li; Yingxiu Cao; Yingjin Yuan
Journal:  Sci China Life Sci       Date:  2021-03-02       Impact factor: 6.038

Review 7.  Genome-driven cell engineering review: in vivo and in silico metabolic and genome engineering.

Authors:  Sophie Landon; Joshua Rees-Garbutt; Lucia Marucci; Claire Grierson
Journal:  Essays Biochem       Date:  2019-07-03       Impact factor: 8.000

8.  Efficient correction of a deleterious point mutation in primary horse fibroblasts with CRISPR-Cas9.

Authors:  Carlos Pinzon-Arteaga; Matthew D Snyder; Cicera R Lazzarotto; Nicolas F Moreno; Rytis Juras; Terje Raudsepp; Michael C Golding; Dickson D Varner; Charles R Long
Journal:  Sci Rep       Date:  2020-05-04       Impact factor: 4.379

9.  Future Preventive Gene Therapy of Polygenic Diseases from a Population Genetics Perspective.

Authors:  Roman Teo Oliynyk
Journal:  Int J Mol Sci       Date:  2019-10-10       Impact factor: 5.923

10.  Multiplexed genomic encoding of non-canonical amino acids for labeling large complexes.

Authors:  Bijoy J Desai; Ruben L Gonzalez
Journal:  Nat Chem Biol       Date:  2020-07-20       Impact factor: 15.040

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.